Source: Annals of Hematology. Unidades: FMRP, FM
Subjects: ANEMIA, MEDULA ÓSSEA, CICLOSPORINAS, SOBREVIVÊNCIA LIVRE DE DOENÇA
ABNT
CLÉ, Diego Villa et al. Rabbit antithymocyte globulin dose does not affect response or survival as first-line therapy for acquired aplastic anemia: a multicenter retrospective study. Annals of Hematology, v. 97, n. 11, p. 2039-2046, 2018Tradução . . Disponível em: https://doi.org/10.1007/s00277-018-3416-4. Acesso em: 19 nov. 2024.APA
Clé, D. V., Atta, E. H., Dias, D. S. P., Lima, C. B. L., Bonduel, M., Sciuccati, G., et al. (2018). Rabbit antithymocyte globulin dose does not affect response or survival as first-line therapy for acquired aplastic anemia: a multicenter retrospective study. Annals of Hematology, 97( 11), 2039-2046. doi:10.1007/s00277-018-3416-4NLM
Clé DV, Atta EH, Dias DSP, Lima CBL, Bonduel M, Sciuccati G, Medeiros LA, Oliveira MM de, Fonseca PBB, Saad STO, Hamerschlak N, Salvino MA, Garanito MP, Pazin Filho A, Scheinberg P, Calado RT. Rabbit antithymocyte globulin dose does not affect response or survival as first-line therapy for acquired aplastic anemia: a multicenter retrospective study [Internet]. Annals of Hematology. 2018 ; 97( 11): 2039-2046.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1007/s00277-018-3416-4Vancouver
Clé DV, Atta EH, Dias DSP, Lima CBL, Bonduel M, Sciuccati G, Medeiros LA, Oliveira MM de, Fonseca PBB, Saad STO, Hamerschlak N, Salvino MA, Garanito MP, Pazin Filho A, Scheinberg P, Calado RT. Rabbit antithymocyte globulin dose does not affect response or survival as first-line therapy for acquired aplastic anemia: a multicenter retrospective study [Internet]. Annals of Hematology. 2018 ; 97( 11): 2039-2046.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1007/s00277-018-3416-4